✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Bal Pharma Ltd.

BALPHARMA

Market Cap
₹178 Cr.
P/E
24.53

Bal Pharma Ltd.

  • Bal Pharma
  • Tyche Inds
  • Smruthi Organics
  • TJI Pharma - Small Cap
FAQs on Bal Pharma Ltd. Shareprice

Bal Pharma has given lower returns compared to its competitors.
Bal Pharma has grown at ~3.79% over the last 7yrs while peers have grown at a median rate of 5.41%

Bal Pharma is not expensive.
Latest PE of Bal Pharma is 24.53, while 3 year average PE is 31.14.
Also latest EV/EBITDA of Bal Pharma is 10.13 while 3yr average is 10.74.

View FAQ's On Business
Growth Table
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Balance Sheet
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Cash Flow
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Quarterly Results
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Bal Pharma Ltd. Financials

Balance sheet of Bal Pharma is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Bal Pharma is increasing.
Latest debt of Bal Pharma is ₹141 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹113 Crs.

The profit is oscillating.
The profit of Bal Pharma is ₹7.35 Crs for TTM, ₹7.39 Crs for Mar 2024 and ₹2.57 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bal Pharma latest dividend payout ratio is 25.66% and 3yr average dividend payout ratio is 37.69%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech